Trial Details

TERMINATED
Basic Information
Clinical ID c3753
Identifier NCT01570348
Trial Title Crohn's Allogeneic Transplant Study
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn Disease
Interventions PROCEDURE: Allogeneic Bone Marrow Transplantation|DRUG: Cyclophosphamide|DRUG: Fludarabine Phosphate|OTHER: Laboratory Biomarker Analysis|DRUG: Mycophenolate Mofetil|DRUG: Mycophenolic Acid|OTHER: Quality-of-Life Assessment|DRUG: Tacrolimus|RADIATION: Total-Body Irradiation
Participant Information
Sponsor Fred Hutchinson Cancer Center
City Seattle
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2012-07-17
Primary Completion Date 2019-02-03
Completion Date 2019-10-30